Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
By P. Cheng, Cesar A. Corzo, N. Luetteke, Bin Yu, S. Nagaraj, M. Bui, Myrna L. Ortiz, W. Nacken, C. Sorg, T. Vogl and 2 more. Journal of Experimental Medicine, 2008
949 citations recorded by the source corpus.
Accumulation of myeloid-derived suppressor cells (MDSCs) associated with inhibition of dendritic cell (DC) differentiation is one of the major immunological abnormalities in cancer and leads to suppression of antitumor immune responses. The molecular mechanism of this phenomenon remains unclear. We report here that STAT3-inducible up-regulation of the myeloid-related protein S100A9 enhances MDSC production in cancer. Mice lacking this protein mounted potent antitumor immune responses and rejected implanted tumors. This effect was reversed by administration of wild-type MDSCs from tumor-bearing mice to S100A9-null mice. Overexpression of S100A9 in cultured embryonic stem cells or transgenic mice inhibited the differentiation of DCs and macrophages and induced accumulation of MDSCs. This study demonstrates that tumor-induced up-regulation of S100A9 protein is critically important for accumulation of MDSCs and reveals a novel molecular mechanism of immunological abnormalities in cancer.
Subfields: Immunology, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/7a4acc2eec4089674a697f34dd4389e1aeaad8af
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
In Molecular Biology
Citations in the corpus
- Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. (2010, background): “Moreover, we also provided evidence indicating that mouse and human MDSCs can be generated through a simple, short-term culture system by a combination of cytokines that are normally released under inflammatory conditions but are also present in tumor microenvironment, further confirming the link be”
- Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer (2009, background): “STAT3 also induces expression of calcium binding S100A9 protein, which is specifically required for tumorigenesis and attraction of MSDC (84).”
- Functions of S100 Proteins (2012, background): “S100A9 may modulate tolerogenic dendritic cell-T cell activation by reducing B7 levels and subsequent T-cell priming [237], and its over-expression inhibits dendritic cell differentiation [59].”
- Tumor‐associated macrophages (TAM) as major players of the cancer‐related inflammation (2009, background): “In addition, Sinha and colleagues [120] demonstrated a reduced recruitment of MDSCs at the tumor site after anti S100-A8 or S100-A9 protein administrations [143].”
- Mechanism regulating reactive oxygen species in tumor induced myeloid-derived suppressor cells (2009, background): “Thus, it appears that abnormal persistent activation of STAT3 in myeloid progenitors prevents differentiation of myeloid cells and is associated with increased proliferation and survival of myeloid progenitors, possibly through up-regulation of STAT3-targeted genes like Bcl-xL, cyclin D1, c-myc, sur”
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer (2009, background): “phages through a STAT3-dependent mechanism (96); and 2)”
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment (2010, methodology): “Expansion of IMCs in BM of tumorbearing hosts, which is governed in large part by up-regulation of STAT3 (Nefedova et al., 2004; Cheng et al., 2008; Kujawski et al., 2008), results in an accumulation of MDSC in JEM VOL. 207, October 25, 2010 Article 2451 qRT-PCR RNA was extracted with Trizol…”
- Coordinated regulation of myeloid cells by tumours (2012, background): “STAT3-mediated upregulation of these proteins in myeloid progenitors inhibits DC differentiation and promotes MDSC accumulatio”